TERF1 and neoplasm: In prostate cancer, tRF-1001 (tRF3-Ser) overexpression can reduce tumor cell proliferation [80], while Olvedy et al. and Yang et al. found that inhibiting tRF-315 expression led to cellular stress and activation of prostate cancer cell apoptosis [83].